Vivani Medical
VANI
20 hedge funds and large institutions have $819K invested in Vivani Medical in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0.64% less ownership
Funds ownership: 1.85% → 1.21% (-0.64%)
5% less funds holding
Funds holding: 21 → 20 (-1)
5% less capital invested
Capital invested by funds: $865K → $819K (-$45.4K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
VANI Hedge Fund Activity: Q2 2020 in Review
20 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2020, worth a combined $819K — down 5.3% from $865K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VANI and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 3 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $30.3K. The largest seller was Vanguard Group, cutting an estimated $70K.
- 20 institutional investors held Vivani Medical (VANI) as of Q2 2020, down from 21 in Q1 2020.
- Funds reported $819K of Vivani Medical stock for Q2 2020, down 5.3% quarter-over-quarter.
- 4 funds opened new Vivani Medical positions in Q2 2020 and 5 closed out, a net change of -1 holder.
- The largest Vivani Medical buyer in Q2 2020 was Millennium Management, an estimated $30.3K added.
- The largest Vivani Medical seller in Q2 2020 was Vanguard Group, an estimated $70K sold.
Based on aggregated 13F filings for Q2 2020.